CA50828-2 - 0x0000000000006D20

Males & Females of Non-Childbearing Potential

Courtyard

* Stipend may pay up to reflected amount.
Start Date: 
June 8, 2026 - 2:15pm
End Date: 
July 27, 2026 - 11:45am

Study Details

Study Number: CA50828
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $13,000.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat Cushing's syndrome.
Route of Administration: Injection IV bolus/push; Oral
Blood Draws: 58

Study Schedule

Schedule Type: Long Term
Study Length: 22 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Tuesday 5/26/2026
Wednesday 5/27/2026
Monday 6/1/2026
Thursday 6/4/2026
Friday 6/5/2026
Monday 6/8/2026

Doctor Exam Dates:

Event Day Event Date
Tuesday 5/26/2026
Wednesday 5/27/2026
Monday 6/1/2026
Thursday 6/4/2026
Friday 6/5/2026
Monday 6/8/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 6/8/2026 2:15:00 PM Tuesday 6/30/2026 5:45:00 PM 1 Lincoln
Phone participant Monday 7/27/2026 11:45:00 AM 1 Lincoln